Physician profile
Brian Stone
NPI 1558470823
$7,828.42
in general payments reported to CMS, 2019-2025
29 companies · $2,356 in 2025
The $2,356 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.15 · 2020: $218 · 2021: $851 · 2022: $790 · 2023: $562 · 2024: $2,993 · 2025: $2,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,852 · Travel and Lodging: $1,810 · Entertainment: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,851.57 |
| Travel and Lodging | $1,809.94 |
| Entertainment | $248.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,446.28 | 2025 | |
| Boston Scientific Corporation | $1,332.07 | 2019-2025 | Lithovue |
| Axonics, INC. | $1,273.30 | 2020-2024 | Axonics, Bulkamid |
| Coloplast Corp | $819.58 | 2019-2025 | Titan |
| Intuitive Surgical, INC. | $661.96 | 2024 | |
| Medtronic, INC. | $524.87 | 2022-2025 | Interstim |
| Progenics Pharmaceuticals, INC. | $437.33 | 2023-2025 | Pylarify |
| Astellas Pharma US INC | $285.53 | 2022 | |
| Olympus America INC. | $257.63 | 2024-2025 | Itind System, Soltive, Bovie |
| Dendreon Pharmaceuticals LLC | $111.09 | 2025 | Provenge |
| Ferring Pharmaceuticals INC. | $85.86 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $81.66 | 2025 | Erleada, Carvykti, Rybrevant |
| Palette Life Sciences, INC. | $80.92 | 2023 | |
| Conmed Corporation | $47.92 | 2023-2024 | Airseal |
| Blue Earth Diagnostics | $44.32 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $36.51 | 2025 | Xyosted |
| Sumitomo Pharma America, INC. | $33.11 | 2023 | Gemtesa |
| Enterra Medical, INC. | $33.08 | 2022 | |
| Calyxo, INC. | $32.02 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $27.00 | 2025 | Barrigel |
| Urogen Pharma, INC. | $24.37 | 2025 | |
| Myriad Genetic Laboratories, INC. | $23.68 | 2025 | Prolaris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.57 | 2024 | |
| Bluewind Medical | $23.50 | 2024 | Revi |
| Pfizer INC. | $18.44 | 2025 | |
| Procept Biorobotics Corporation | $17.58 | 2024 | Aquabeam System |
| Abbvie INC. | $17.56 | 2022 | |
| Ambu INC. | $15.32 | 2025 | |
| Medtronic USA, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.